Australia markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
23.43+0.61 (+2.67%)
At close: 04:00PM EDT
23.43 0.00 (0.00%)
After hours: 04:08PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
280,259
280,259
161,855
103,303
50,294
Selling general and administrative
87,589
87,589
58,243
45,813
33,169
Total operating expenses
367,848
367,848
220,098
149,116
83,463
Operating income or loss
-367,848
-367,848
-220,098
-149,116
-83,463
Total other income/expenses net
6,878
6,878
-5,393
-3,274
-46,433
Income before tax
-351,351
-351,351
-225,334
-152,166
-128,344
Income tax expense
160
160
0
-24
45
Income from continuing operations
-351,511
-351,511
-225,334
-152,142
-128,389
Net income
-351,511
-351,511
-225,334
-152,142
-128,389
Net income available to common shareholders
-351,511
-351,511
-225,334
-152,142
-128,389
Basic EPS
-
-
-1.65
-2.01
-1.01
Diluted EPS
-
-
-1.65
-2.01
-1.01
Basic average shares
-
-
136,577
73,643
127,124
Diluted average shares
-
-
136,577
73,643
127,124
EBITDA
-
-362,945
-217,367
-148,719
-83,286